首页> 美国卫生研究院文献>Pulmonary Circulation >Understanding the current status of patients with pulmonary hypertension during COVID-19 outbreak: a small-scale national survey from China
【2h】

Understanding the current status of patients with pulmonary hypertension during COVID-19 outbreak: a small-scale national survey from China

机译:了解Covid-19爆发期间肺动脉高压患者的现状:来自中国的小规模国家调查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pulmonary hypertension is a chronic disease developing progressively with high mortality. Pulmonary hypertension patients need persistent medical care; however, limited reports focused on them when there was an outbreak of coronavirus disease 2019 in China. This national survey was aimed to evaluate the overall condition of pulmonary hypertension patients during this period. A questionnaire regarding the living condition of pulmonary hypertension patients during coronavirus disease 2019 was designed by pulmonary hypertension diagnostic experts in Wuhan Asia Heart Hospital. Pulmonary hypertension patients and their family members were invited to participate in this survey online. One-hundred twenty pulmonary hypertension patients and 23 family members participated in the survey; 64.8% (n = 87) participants came from Hubei, and others were from 15 other provinces; 98.6% (n = 141) participants were in home quarantine; 65.8% (n = 79) were pulmonary arterial hypertension associated with congenital heart disease; and 76.7% (n = 92) patients proclaimed their heart function was well maintained at class I or II. One (0.8%) patient was confirmed severe acute respiratory syndrome coronavirus 2 infection. Two (1.7%) patients were hospitalized due to heart function worsening. Nearly 70% (n = 100) participants implied shortage in medications during coronavirus disease 2019 outbreak. A total of 24.2% (n = 29) patients indicated that medications were discontinued due to the insufficient supply. Most of the participants stayed optimistic on either coronavirus disease 2019 outbreak or their pulmonary hypertension disease, and 61.7% (n = 74) patients would go to the hospital for follow-up immediately after outbreak. These preliminary data show pulmonary hypertension patients are able to avoid severe disease when they are in home quarantine. Medication supplement is important for pulmonary hypertension patients when their heart function is well maintained. In addition, there might be increasing requirements of medical care for pulmonary hypertension patients after the outbreak.
机译:肺动脉高压是一种慢性疾病,逐渐发育高死亡率。肺动脉高压患者需要持久的医疗保健;但是,当中国2019年冠状病毒疾病爆发时,有限的报告集中在他们身上。该国家调查旨在在此期间评估肺动脉高压患者的整体病症。武汉亚洲心脏病院肺动脉高压诊断专家设计了关于肺动脉血管疾病患者肺动脉高压患者患者的致病病因的调查问卷。邀请肺动脉高压患者及其家人在线参加本调查。一百二十二十个肺动脉高压患者和23名家庭成员参加了调查; 64.8%(n = 87)参与者来自湖北,其他人来自其他15个省份; 98.6%(n = 141)参与者在预检询中; 65.8%(n = 79)是与先天性心脏病相关的肺动脉高血压;和76.7%(n = 92)令患者宣布他们的心脏功能在I级或II级保持良好。一(0.8%)患者被证实严重急性呼吸综合征冠状病毒2感染。由于心脏功能恶化,两种(1.7%)患者被住院治疗。近70%(n = 100)参与者在冠状病毒疾病2019年爆发期间暗示了药物短缺。共24.2%(n = 29)患者表明,由于供应不足,药物被停止。大多数参与者对2019年冠心病疫情或其肺动脉高压疾病持乐观态度,61.7%(n = 74)患者将在爆发后立即到医院进行随访。这些初步数据显示肺动脉高压患者能够在家庭检疫时避免严重疾病。当它们的心脏功能保持良好时,药物补充剂对于肺动脉高压患者来说是重要的。此外,爆发后可能会增加肺动脉高压患者的医疗保健要求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号